Cumings (1953, 1955) showed that demyelination of the human brain caused by multiple sclerosis resulted in a loss of free cholesterol and the appearance of cholesterol esters in the involved areas. Cholesterol is a principal constituent of myelin and, according to Cumings, exists in the normal brain entirely as the free non-esterified sterol. It seemed of interest to determine the cholesterol content of the cerebrospinal fluid, and the proportion of free to esterified cholesterol normally present. The possibility existed that the total concentration and state of the cholesterol was different in the cerebrospinal fluid of patients with multiple sclerosis, reflecting the changes in the brain. The cerebrospinal fluid was chosen for this study rather than the blood serum because it is in direct contact with areas of demyelination. Also, small changes in the large serum " pool " of cholesterol might be difficult to evaluate.
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A procedure for the accurate determination of small amounts of cholesterol and cholesterol ester in the cerebrospinal fluid was devised. This was based upon a new method for the extraction of cholesterol developed in this laboratory (Roboz, Hess, Di Nella, and Cevallos, 1958) and a new technique for separating free and esterified cholesterol by silicic acid column chromatography (Fillerup and Mead, 1953) .
The cholesterol and cholesterol ester concentrations in the cerebrospinal fluid were determined in a group of patients with a firmly established diagnosis of multiple sclerosis. These results are compared with values obtained in normal individuals and in a series of patients with various neurological disorders.
Since the cerebrospinal fluid y globulin concentration is thought to be an aid in the diagnosis of multiple sclerosis, this was determined and the results compared with the cholesterol concentration.
Materials and Methods
Cerebrospinal fluid was obtained by lumbar puncture from most of the 53 patients included in this study. In a minority of cases fluid removed during air studies was utilized. The diagnosis of each patient was established by a thorough history and neurological examination, combined with air studies and arteriography where indicated. Especially strict criteria were applied in the selection of 13 multiple sclerosis patients. A history of remission and exacerbation was present in most, and all had evidence of dissemination of lesions. The onset of the disease in all cases was before the age of 40 years.
Included in the sample of neurological diseases were eight patients with seizures. A few represented idiopathic epilepsy while most were probably symptomatic. Each had a pneumoencephalogram taken but this failed to demonstrate a neoplasm.
In addition to routine studies the y-globulin concentration in the cerebrospinal fluid of the multiple sclerosis patients was determined by the zinc sulphate precipitation technique reported by Roboz, Hess, and Forster (1953) . Values over 5 mg. per 100 ml. are considered elevated in this laboratory.
Cholesterol and cholesterol ester were extracted from 10 ml. of cerebrospinal fluid by the method of Roboz and others (1958) and determined by the chromatographic technique of Papadopoulos, Cevallos, and Hess (1958) . This method utilizes a silicic acid column and the selective elution of free and ester cholesterol followed by their colorimetric estimation.
Results
Since it was desirable to perform the cholesterol analysis on 10 ml. of cerebrospinal fluid, it was difficult to survey a large number of normal individuals. The y-globulin concentration was elevated in seven of the patients with multiple sclerosis. The y-globulin and percentage of cholesterol as ester were both increased in three patients. Abnormalities of one or the other of these two determinations were present in nine of the 13 cases.
Although this report is not primarily concerned with serum cholesterol levels, the relationship between serum and cerebrospinal fluid cholesterol content is of interest. A patient with myxoedema had a serum cholesterol level of 406 mg. per 100 ml. (normal: 50 to 250), and a cerebrospinal fluid level of0 55 mg. per 100 ml. Two other patients with serum levels of 288 and 256 mg. per 100 ml. had cerebrospinal fluid values of 0 57 and 0 50 respectively. Discussion Plaut and Rudy (1933) investigated the cholesterol content of the cerebrospinal fluid in neurological diseases but did not determine the cholesterol ester fraction. They reported a normal level varying from 0-06 to 0-22 mg. per 100 ml., although they indicated that cholesterol may be absent from normal cerebrospinal fluid. They found an increase of cholesterol in patients with cerebral arteriosclerosis, dementia paralytica, brain tumour, brain abscess, and other diseases. Patients with multiple sclerosis were evidently not studied. It is significant that Plaut and Rudy found a lower level of total cholesterol in their controls than we did. The method of determination employed by these investigators was less sensitive than the modern methods utilized in this study, a fact which was emphasized by their occasional failure to find cholesterol in the cerebrospinal fluid samples. The separation and determination of very small quantities of cholesterol and cholesterol ester has only recently been made practicable by the application of column chromatography.
It is not surprising that destruction of brain or spinal cord tissue by various disease processes was accompanied by an increased cholesterol content of the cerebrospinal fluid. The human brain, and especially the white matter, is rich in cholesterol which may be released into the cerebrospinal fluid. Both this study, and the work of Plaut and Rudy, indicate that increased serum cholesterol levels do not influence the cerebrospinal fluid concentration in patients without neurological disease.
Increased levels of both free and esterified cholesterol were found in the cerebrospinal fluid of patients with cerebral infarction, brain tumour, and head trauma, as well as in multiple sclerosis. The multiple sclerosis group was separated from the other diagnostic categories by the presence in several cases of a cholesterol ester fraction which constituted over 60% of the total cholesterol. This finding correlates well with the observations of Cumings (1955) . The decrease in free cholesterol and the appearance of cholesterol ester in demyelinated areas of the brains of patients with multiple sclerosis, reported by this worker, is thus reflected by an augmented proportion of cholesterol as ester in the cerebrospinal fluid. The data are insufficient to establish a correlation betwen the cerebrospinal fluid results and the activity of demyelination; more patients must be studied. An extension of this series is also desirable since the low y-globulin levels of several of the multiple sclerosis patients are contrary to previous experience in this laboratory and may indicate that this group was not fully representative of the disease. If further studies now in progress confirm this report, the determination of the percentage of esterified cholesterol in the cerebrospinal fluid may well be a valuable aid to the diagnosis of multiple sclerosis.
Summary
The cholesterol and cholesterol ester content of the cerebrospinal fluid was determined in six normal individuals, 13 patients with multiple sclerosis, and 34 patients with other neurological diseases. While levels of free and esterified cholesterol were raised in the cerebrospinal fluid of patients with a variety of neurological diseases, only multiple sclerosis patients were characterized by a proportion of ester which was over 60% of the total cholesterol. This finding correlates well with previous investigations of demyelinated tissue by Cumings. It is concluded that the determination of the percentage of esterified cholesterol in the cerebrospinal fluid is a promising adjunct in the diagnosis of multiple sclerosis.
